GI
PTCT icon

GAMMA Investing’s PTC Therapeutics PTCT Stock Holding History

GAMMA Investing’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
1,453
+534
+58% +$38.6K ﹤0.01% 1680
2026
Q1 		$62.6K Sell
919
-532
-37% -$37.7K ﹤0.01% 2030
2025
Q4 		$110K Buy
1,451
+893
+160% +$64.9K 0.01% 1503
2025
Q3 		$34.2K Buy
558
+40
+8% +$2.08K ﹤0.01% 2227
2025
Q2 		$25.3K Sell
518
-434
-46% -$20.6K ﹤0.01% 2342
2025
Q1 		$48.5K Buy
952
+441
+86% +$22K ﹤0.01% 1810
2024
Q4 		$23.1K Buy
511
+274
+116% +$11.7K ﹤0.01% 2197
2024
Q3 		$8.79K Buy
237
+126
+114% +$4.22K ﹤0.01% 2516
2024
Q2 		$3.39K Buy
111
+21
+23% +$680 ﹤0.01% 2709
2024
Q1 		$2.62K Buy
90
+23
+34% +$644 ﹤0.01% 2666
2023
Q4 		$1.75K Buy
+67
New +$1.53K ﹤0.01% 2615

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

GAMMA Investing's PTCT Position: Q2 2026 in Review

GAMMA Investing increased its PTC Therapeutics (PTCT) stake by 58% in Q2 2026, buying an estimated $38.6K and bringing the position to 1,453 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

GAMMA Investing first reported a position in PTCT in Q4 2023 and has held it in 11 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • GAMMA Investing held 1,453 shares of PTC Therapeutics worth $119K as of Q2 2026.
  • GAMMA Investing bought 534 PTC Therapeutics shares in Q2 2026, an estimated $38.6K.
  • PTC Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1680 holding.
  • GAMMA Investing first reported a position in PTC Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.